AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2016

May 12, 2016

Director's Dealing

Opens in your device viewer

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2016-05-12

Reporting Person: KIDRON NADAV (Director, President and CEO, 10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-12	Common Stock	P	300	$6.90	Acquired	957448	Direct
2016-05-12	Common Stock	P	300	$6.91	Acquired	957748	Direct
2016-05-12	Common Stock	P	300	$7.00	Acquired	958048	Direct
2016-05-12	Common Stock	P	100	$7.10	Acquired	958148	Direct